cephaloglycine | 2258-32-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酰胺类
• 英文名称: cephaloglycine
• 英文别名: (6R,7R)-3-(acetyloxymethyl)-7-[(2-amino-2-phenylacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• CAS: 2258-32-4
• 化学式: C₁₈H₁₉N₃O₆S
• 分子量: 405.431
• InChiKey: FUBBGQLTSCSAON-QQGYXAEISA-N

物化性质

• 沸点：
  761.8±60.0 °C(Predicted)
• 密度：
  1.52±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -3
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  164
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  cephaloglycine 在 吡啶 、 氯化亚砜 、 N-甲基-N-(三甲基硅烷基)三氟乙酰胺 作用下， 以 水 、 乙腈 为溶剂， 反应 3.0h， 以31%的产率得到(6R,7R)-3-Acetoxymethyl-8-oxo-7-(3-oxo-4-phenyl-3H-[1,2,5]thiadiazol-2-yl)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  参考文献：
  名称：

  轻松合成3-oxo-1,2,5-噻二唑; 7β-s̆（3-氧代-1,2,5-噻二唑-2-基）头孢菌素

  摘要：

  描述了在温和条件下制备3-氧代-1,2,5-噻二唑的简单方法。该方法提供了迄今未知的7β-s̆（3-氧代-1,2,5-噻二唑-2-基）头孢菌素。

  DOI：

  10.1016/s0040-4020(01)89437-0
• 作为产物：
  描述：

  ethoxycarbothioyl 2-amino-2-phenylacetate 、 7-氨基头孢烷酸 生成 cephaloglycine
  参考文献：
  名称：

  JAPELJ, M.;VITEZIC, N., VESTN. SLOVEN. KEM. DRUS., 37,(1990) N, C. 459-480

  摘要：

  DOI：

文献信息

• 6- or 7-beta-[2-[4-(substituted)-2,3-dioxopiperazin-1-yl) carbonylamino]-(substituted)acetamido]-penicillin and cephalosporin derivatives
  申请人：BEECHAM GROUP PLC

  公开号：EP0293532A1

  公开（公告）日：1988-12-07

  Antibacterial agents have the formula (I) or are pharmaceutically acceptable salts or in vivo hydrolysable esters thereof: in which Y¹ is oxygen, sulphur or -CH₂ and Z represents hydrogen, halogen, C1-4 alkoxy, -CH₂-Q or -CH=CH-Q where Q represents hydrogen, halogen, hydroxy, mercapto, cyano, carboxy, carboxylic ester, C1-4 alkyloxy, acyloxy, aryl, a heterocyclyl group bonded via carbon, a heterocyclylthio group or a nitrogen containing heterocyclic group bonded via nitrogen; R⁵ represents phenyl, substituted phenyl, cyclohexenyl, cyclohexadienyl or an optionally substituted 5 or 6-membered heterocyclic ring containing up to three hetero atoms selected from oxygen, sulphur or nitrogen, R⁶ is hydrogen, hydroxymethyl, formamido, or methoxy, R⁷ and R⁸ are the same or different and represent hydrogen, C1-6 alkyl, substituted C1-6 alkyl, halogen, amino, phenyl, substituted phenyl, hydroxy or C1-6 alkoxy or R⁷ and R⁸ form the residue of an optionally substituted 5 or 6- membered carbocyclic ring or a 5 or 6-membered heterocyclic ring containing up to three hetero atoms selected from oxygen, sulphur or nitrogen, R⁹ is wherein R¹⁰ and R¹¹ are the same or different and each represents hydroxy, or protected hydroxy and XR⁹ is -(CH₂)nR⁹, -NHCOR⁹, -N=CHR⁹, -NHCH₂R⁹, or -COR⁹, where n is from 0 to 2; with the proviso that XR⁹ does not represent -N=CHR⁹ when R⁶ represents hydrogen. The use of the compounds is described together with intermediates for their preparation.

  抗菌剂的化学式为（I），或者是其药用可接受盐或体内水解酯： 其中Y¹为氧、硫或-CH₂，Z代表氢、卤素、C1-4烷氧基、-CH₂-Q或-CH=CH-Q，其中Q代表氢、卤素、羟基、巯基、氰基、羧基、羧酸酯、C1-4烷氧基、酰氧基、芳基、通过碳键合的杂环基、杂环硫基或通过氮键合的含氮杂环基； R⁵代表苯基、取代苯基、环己烯基、环己二烯基或一个可选择取代的含有最多三个氧、硫或氮杂原子的5或6元杂环环，R⁶为氢、羟甲基、甲酰胺基或甲氧基，R⁷和R⁸相同或不同，代表氢、C1-6烷基、取代C1-6烷基、卤素、氨基、苯基、取代苯基、羟基或C1-6烷氧基，或R⁷和R⁸形成一个可选择取代的5或6元碳环或一个含有最多三个氧、硫或氮杂原子的5或6元杂环环，R⁹为 其中R¹⁰和R¹¹相同或不同，每个代表羟基或保护羟基，XR⁹为-(CH₂)nR⁹、-NHCOR⁹、-N=CHR⁹、-NHCH₂R⁹或-COR⁹，其中n为0至2；但XR⁹不代表-N=CHR⁹当R⁶代表氢时。 描述了这些化合物的用途以及其制备的中间体。
• Semisynthetic .BETA.-lactam antibiotics. 8. Structure-activity relationships of .ALPHA.-sulfocephalosporins.
  作者：HIROAKI NOMURA、ISAO MINAMI、TAKENORI HITAKA、TAKESHI FUGONO

  DOI：10.7164/antibiotics.29.928

  日期：——

  Synthesis and in vitro activity of a number of cephalosporins having α-sulfoacyl- or other acyl groups, e.g., α-carboxyacyl- and α-sulfoaminoacyl- at the 7-position and bearing a variety of heterocyclic thioether or pyridinium moieties at the 3-position are described.

  介绍了一些头孢菌素的合成和体外活性，这些头孢菌素在 7 位上具有 α-磺酰基或其他酰基，如 α-羧酰基和 α-磺酰胺酰基，在 3 位上具有各种杂环硫醚或吡啶基。
• Penicillin derivatives
  申请人：Nippon Chemiphar Company Limited

  公开号：US04219477A1

  公开（公告）日：1980-08-26

  Penicillin and cephalosporin derivatives and non-toxic salts thereof represented by the formula (1), ##STR1## wherein Ar represents a phenyl or heterocyclic group which may be substituted by a halogen atom, or a hydroxy or lower alkoxy group, R represents a hydrogen atom or a hydroxy group, X represents CH or N, ##STR2## 1 and n are integers of 0 or 1 wherein the sum equal to 1 and n is 0 or 1, and m is an integer equal to 1 or 2 are useful antibiotics.

  盐酸青霉素和头孢菌素衍生物及其非毒性盐，其化学式为（1）：##STR1## 其中Ar代表可以被卤素、羟基或较低的烷氧基取代的苯基或杂环基，R代表氢原子或羟基，X代表CH或N，##STR2## 1和n是0或1的整数，其和等于1且n为0或1，m是1或2的整数，是有用的抗生素。
• Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5R) penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
  申请人：PFIZER INC.

  公开号：EP0074783A1

  公开（公告）日：1983-03-23

  Beta-lactamase inhibiting 2-beta-substituted-2-alphamethyl-(5R)penam-3-alpha-carboxylic acid 1,1-dioxides and esters thereof, wherein the 2-beta-substituent is cyano, acetyl, alkoxycarbonyl, omegahydroxyalkoxycarbonyl, car- balkoxymethoxycarbonyl or dialkylaminocarbonyl; intermediates therefor wherein the 2-beta-substituent is carboxy, chlorocarbonyl or aminocarbonyl; methods for their preparation and use as beta-lactamase inhibitors.

  抑制β-内酰胺酶的2-beta-取代基-2-樟脑甲基-(5R)戊-3-α-羧酸1,1-二氧化物及其酯类，其中2-beta-取代基为氰基、乙酰基、烷氧基羰基、ω-羟基烷氧基羰基、car- balkoxymoxycarbonyl或二烷基氨基羰基；其中2-beta-取代基为羧基、氯羰基或氨基羰基的中间体；其制备方法和作为β-内酰胺酶抑制剂的用途。
• Penicillanic acid dioxide prodrug
  申请人：PFIZER INC.

  公开号：EP0095341A1

  公开（公告）日：1983-11-30

  A compound of the formula is a prodrug of 4,4-dioxopenicillanic acid, wherein R is hydrogen or methyl; R R2 and R3 (a) when taken individually are each alkyl containing one to four carbon atoms, or (b) when taken together with the nitrogen to which they are attached form a five- or six-membered saturated monocyclic moiety, an eight-membered saturated bicyclic moiety or a five- or six-membered aromatic cyclic moiety annulated with zero, one or two fused benzene rings, with the proviso that any Ri, R2 or R3 not part of a cyclic moiety is alkyl containing one to four carbon atoms; and X- is a pharmaceutically-acceptable anion. The prodrug can be included with a beta-lactam antibiotic in a pharmaceutical composition which can be employed in the treatment of infection in mammals. The above-described compounds hydrolyze in vivo to 4.4-dioxopenicillanic acid.

  式中的化合物 是 4,4-二氧代青霉烷酸的原药，其中 R 是氢或甲基；R R2 和 R3 (a) 单个时均为含 1 至 4 个碳原子的烷基，或 (b) 与所连接的氮一起形成五元或六元饱和单环分子、八元饱和双环分子或环有 0、1 或 2 个融合苯环的五元或六元芳香环分子，但任何不属于环分子的 Ri、R2 或 R3 均为含 1 至 4 个碳原子的烷基；X- 是药学上可接受的阴离子。该原药可与β-内酰胺类抗生素一起加入药物组合物中，用于治疗哺乳动物的感染。上述化合物在体内水解为 4.4-二氧代青霉烷酸。